- Home
- TECX vs CGC Comparison
TECX vs CGC Comparison
Compare TECX & CGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TECX
- CGC
- Stock Information
- Founded
- TECX 2019
- CGC N/A
- Country
- TECX United States
- CGC Canada
- Employees
- TECX N/A
- CGC N/A
- Industry
- TECX
- CGC Pharmaceuticals and Biotechnology
- Sector
- TECX
- CGC Health Care
- Exchange
- TECX Nasdaq
- CGC Nasdaq
- Market Cap
- TECX 387.1M
- CGC 431.7M
- IPO Year
- TECX 2018
- CGC N/A
- Fundamental
- Price
- TECX $16.01
- CGC $1.45
- Analyst Decision
- TECX Buy
- CGC Hold
- Analyst Count
- TECX 6
- CGC 1
- Target Price
- TECX $79.17
- CGC N/A
- AVG Volume (30 Days)
- TECX 475.2K
- CGC 22.3M
- Earning Date
- TECX 11-06-2025
- CGC 11-07-2025
- Dividend Yield
- TECX N/A
- CGC N/A
- EPS Growth
- TECX N/A
- CGC N/A
- EPS
- TECX N/A
- CGC N/A
- Revenue
- TECX N/A
- CGC $201,572,742.00
- Revenue This Year
- TECX N/A
- CGC $13.24
- Revenue Next Year
- TECX N/A
- CGC $3.68
- P/E Ratio
- TECX N/A
- CGC N/A
- Revenue Growth
- TECX N/A
- CGC N/A
- 52 Week Low
- TECX $13.70
- CGC $0.77
- 52 Week High
- TECX $61.07
- CGC $5.80
- Technical
- Relative Strength Index (RSI)
- TECX 34.36
- CGC 52.66
- Support Level
- TECX $15.92
- CGC $1.35
- Resistance Level
- TECX $18.61
- CGC $1.47
- Average True Range (ATR)
- TECX 1.58
- CGC 0.14
- MACD
- TECX -0.46
- CGC -0.02
- Stochastic Oscillator
- TECX 5.59
- CGC 22.58
About TECX Tectonic Therapeutic Inc. Common Stock
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.
About CGC Canopy Growth Corporation
Canopy Growth Corp, cultivates and sells medicinal and recreational cannabis and hemp through a portfolio of brands that include Doja, LivRelief, Ace Valley, Deep Space, and others. The Company is engaged in reportable segments namely: Canada cannabis, International markets cannabis, Storz & Bickel, and This Works. The company generates maximum revenue from Canadian cannabis.